These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8217827)

  • 1. Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.
    Goodfield MJ; Orchard MA; Rowell NR
    Br J Haematol; 1993 Aug; 84(4):675-80. PubMed ID: 8217827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
    Kahaleh MB; Osborn I; LeRoy EC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):482-4. PubMed ID: 6782927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro platelet aggregability studies: lack of evidence for platelet hyperactivity in systemic sclerosis.
    Price JE; Klimiuk PS; Jayson MI
    Ann Rheum Dis; 1991 Aug; 50(8):567-71. PubMed ID: 1888199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis.
    Lau CS; McLaren M; Saniabadi A; Belch JJ
    Scand J Rheumatol; 1993; 22(3):97-101. PubMed ID: 8316776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet sensitivity to collagen-induced aggregation in whole blood patients with systemic sclerosis.
    Goodfield MJ; Orchard MA; Rowell NR
    Clin Exp Rheumatol; 1988; 6(3):285-8. PubMed ID: 3180549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma).
    Lee P; Norman CS; Sukenik S; Alderdice CA
    J Rheumatol; 1985 Jun; 12(3):514-7. PubMed ID: 2931522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased platelet function and von Willebrand factor in vibration syndrome.
    Ikehata K; Kawauchi S; Kohno F; Nishiyama M; Ide N
    Tokushima J Exp Med; 1980 Jun; 27(1-2):23-8. PubMed ID: 6968462
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
    López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
    Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma eicosanoids, platelet function and cold sensitivity.
    Wilkinson D; Vowden P; Gilks L; Latif AB; Rajah SM; Kester RC
    Br J Surg; 1989 Apr; 76(4):401-5. PubMed ID: 2720355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.
    Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Miyajima Y; Kazama M
    Acta Haematol; 1992; 88(4):189-93. PubMed ID: 1337960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular function parameters in idiopathic and quartz-induced progressive scleroderma].
    Haustein UF; Scheel H; Siegemund A; Krusche U
    Hautarzt; 1993 Nov; 44(11):717-22. PubMed ID: 8276590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.
    Coller BS; Frank RN; Milton RC; Gralnick HR
    Ann Intern Med; 1978 Mar; 88(3):311-6. PubMed ID: 305223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated platelet sensitivity to collagen in patients with neurofibromatosis type 1.
    Rasko JE; North KN; Favaloro EJ; Grispo L; Berndt MC
    Br J Haematol; 1995 Mar; 89(3):582-8. PubMed ID: 7734358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
    Glueck HI; Kant KS; Weiss MA; Pollak VE; Miller MA; Coots M
    Arch Intern Med; 1985 Aug; 145(8):1389-95. PubMed ID: 3927865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma].
    Cuenca R; Fernández-Cortijo J; Lima J; Fonollosa V; Simeón CP; Pico M; Soriano B; Vilardell M
    Med Clin (Barc); 1990 Dec; 95(20):761-3. PubMed ID: 2151867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.